RevieweLife2020
A perspective on HPK1 as a novel immuno-oncology drug target.
Sansana Sawasdikosol et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this papertrialcites it
RevieweLife2020
Sansana Sawasdikosol et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.